Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Nemaura Medical Inc. - news published 107 - readings 1.187

BACK

Nemaura Medical Inc.

Late Filing Notice Form NT 10 K

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D.C. 20549 Expires: April 30, 2025 Estimated average burden hours per response ... 2.50 FORM 12b-25 001-38355 NOTIFICATION OF LATE FILING SEC FILE NUMBER (Check one): ☒Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: ...

01.07.2024

Nemaura Medical Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders. On May 9, 2024, the Shareholders of Nemaura Medical Inc. (the "Company") approved by written consent to authorize amendments to the Articles of Incorporation of the Company (the "Articles") to effect a reverse stock split of the common stock, par value $0.001 per share, of the Company (the " ...

17.05.2024

Nemaura Medical Inc.

Certificate of Incorporation/Bylaws - Form 8-K

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 28, 2024, Nemaura Medical Inc. (the "Company") filed with the Nevada Secretary of State a certificate of amendment (the "Amendment") to its articles of incorporation, as amended (the "Articles"), to increase the authorized shares of common stock from 42 ...

22.04.2024

Nemaura Medical Inc.

Management Change/Compensation - Form 8-K

Item 1.01. Entry into a Material Definitive Agreement. On April 3, 2024, Nemaura Medical Inc. (the "Company") entered into an Exchange Agreement (the "Uptown Exchange Agreement"), by and among the Company, Dermal Diagnostics Limited ("Dermal"), Trial Clinic Limited ("Trial Clinic" and collectively with the Company and Dermal, the "B ...

10.04.2024

Nemaura Medical Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.07. Submission of Matters to a Vote of Security Holders. On February 26, 2024, Nemaura Medical Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") to vote on the following matters: 1. Election of directors Each of the following four nominees was elected to the Company's Board of Directors, in accordance with the voting ...

26.02.2024

Nemaura Medical Inc.

Quarterly Report for Quarter Ending December 31, 2023 (Form 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2023 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe ...

12.02.2024

Nemaura Medical Inc.

Proxy Statement - Form DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [_] Check the appropriate box: [_] Preliminary Proxy Statement ...

17.01.2024

Nemaura Medical Inc.

Additional Proxy Soliciting Materials - Form DEFA14A

17.01.2024

Nemaura Medical Inc.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

09.01.2024

Nemaura Medical Inc.

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per respo ...

09.01.2024

Nemaura Medical Inc.

Failure to Satisfy Listing Rule - Form 8-K

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on January 3, 2024, Nemaura Medical Inc. (the "Company") issued a press release providing a crucial update regarding recent decisions that will impact the Company's listing status on The Nasdaq Capital Market and its broader strateg ...

03.01.2024

Nemaura Medical Inc.

Important Update on Listing Status and Strategic Direction

January 3, 2024 Important Update on Listing Status and Strategic Direction Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) - Nemaura Medical Inc. ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will impact Nemaura Medi ...

03.01.2024

Nemaura Medical Inc.

Important Update on Listing Status and Strategic Direction - Form 8-K

Important Update on Listing Status and Strategic Direction Loughborough, UK, January 3, 2024 (GLOBE NEWSWIRE) - Nemaura Medical Inc. ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will impact Nemaura Medical's listing ...

03.01.2024

Nemaura Medical Inc.

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

December 13, 2023 Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) - Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the ...

13.12.2023

Nemaura Medical Inc.

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - Form 8-K

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision Loughborough, UK, December 13, 2023 (GLOBE NEWSWIRE) - Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the Company's requ ...

13.12.2023

Nemaura Medical Inc. - news published 107 - readings 1.187

Nemaura Medical Inc.

Late Filing Notice Form NT 10 K

Nemaura Medical Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Nemaura Medical Inc.

Certificate of Incorporation/Bylaws - Form 8-K

Nemaura Medical Inc.

Management Change/Compensation - Form 8-K

Nemaura Medical Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Nemaura Medical Inc.

Quarterly Report for Quarter Ending December 31, 2023 (Form 10-Q)

Nemaura Medical Inc.

Proxy Statement - Form DEF 14A

Nemaura Medical Inc.

Additional Proxy Soliciting Materials - Form DEFA14A

Nemaura Medical Inc.

Statement of Changes in Beneficial Ownership - Form 4

Nemaura Medical Inc.

Initial Statement of Beneficial Ownership - Form 3

Nemaura Medical Inc.

Failure to Satisfy Listing Rule - Form 8-K

Nemaura Medical Inc.

Important Update on Listing Status and Strategic Direction

Nemaura Medical Inc.

Important Update on Listing Status and Strategic Direction - Form 8-K

Nemaura Medical Inc.

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

Nemaura Medical Inc.

Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - Form 8-K

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member